Literature DB >> 10661354

Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas.

A Becker1, P Stadler, R S Lavey, G Hänsgen, T Kuhnt, C Lautenschläger, H J Feldmann, M Molls, J Dunst.   

Abstract

PURPOSE: To investigate the relationship between tumor oxygenation and the blood hemoglobin (Hb) concentration in patients with squamous cell carcinoma of the head and neck (SCCHN). METHODS AND MATERIALS: A total of 133 patients with SCCHN underwent pretreatment polarographic pO2 measurements of their tumors. In 66 patients measurements were also made in sternocleidomastoid muscles. The patients were divided into three groups according to their Hb concentration-severe anemia (Hb < 11.0 g/dl), mild anemia (female: Hb 11.0-11.9 g/dl; male: Hb 11.0-12.9 g/dl), and normal Hb concentration (female: Hb > or =12.0 g/dl; male: > or =13.0 g/dl).
RESULTS: No significant difference in tumor oxygenation could be detected between mildly anemic patients and patients with a normal Hb level. However, the tumor oxygenation in the severely anemic group was significantly below that of each of the other two groups (p < 0.0001). There was no significant difference between the Hb groups in oxygenation of sternocleidomastoid muscles. In a multivariate analysis including Hb group, tumor volume, smoking habits, gender, T-stage, N-stage, and histologic grade a Hb level < 11 g/dl was found to be the strongest predictor for a poor tumor oxygenation. Smoking also had a marginal influence on median pO2.
CONCLUSION: Our data suggest that a low Hb concentration and cigarette smoking contribute to inadequate oxygenation of SCCHN and thus for increased radioresistance. Consequently, Hb correction and abstinence from smoking may significantly improve tumor oxygenation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661354     DOI: 10.1016/s0360-3016(99)00384-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  42 in total

1.  Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Dirk Rades; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Steven E Schild; Christoph Thorns
Journal:  Strahlenther Onkol       Date:  2011-09-19       Impact factor: 3.621

2.  Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.

Authors:  Ming-Huang Chen; Peter Mu-Hsin Chang; Po-Min Chen; Cheng-Hwai Tzeng; Pen-Yuan Chu; Shyue-Yih Chang; Muh-Hwa Yang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-24       Impact factor: 4.553

3.  Erythropoietin in cancer treatment: considerations about Henke's article.

Authors:  Alberto Biete Sola; Felipe A Calvo Manuel; Bernardino Clavo Varas; Cristina Fernández Pérez; Carmen Porto Vázquez; Alejandro de la Torre Tomás; Almudena Zapatero Laborda
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

Review 4.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer.

Authors:  Jin Hwi Kim; Joon Mo Lee; Ki Sung Ryu; Yong Seok Lee; Yong Gyu Park; Soo Young Hur; Keun Ho Lee; Sung Ha Lee
Journal:  Oncologist       Date:  2011-06-24

6.  Adaptive myogenesis under hypoxia.

Authors:  Zhong Yun; Qun Lin; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection.

Authors:  Daniel J Cunningham; Joseph J Kavolus; Michael P Bolognesi; Samuel S Wellman; Thorsten M Seyler
Journal:  J Arthroplasty       Date:  2017-03-31       Impact factor: 4.757

8.  Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification.

Authors:  B Clavo; F Robaina; D Fiuza; A Ruiz; M Lloret; D Rey-Baltar; P Llontop; A Riveros; J Rivero; F Castañeda; S Quintero; N Santana-Rodríguez
Journal:  Clin Transl Oncol       Date:  2016-08-15       Impact factor: 3.405

Review 9.  Hypoxic tumor microenvironment and cancer cell differentiation.

Authors:  Yuri Kim; Qun Lin; Peter M Glazer; Zhong Yun
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

10.  Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.

Authors:  N D Seibold; S E Schild; M P Gebhard; F Noack; U Schröder; D Rades
Journal:  Strahlenther Onkol       Date:  2013-05-24       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.